ADA Scientific Sessions 2025 Abstract

Assessing Disparities in Diabetes Prevention and Obesity Pharmacotherapy Treatment Outcomes among Veterans—A Local Cohort Study

By Diana Torres Pinzon, Jeena Mathew, Juan Vasquez Mendez, José O. Alemán

Study in peopleInterventions

The paper

Diana Torres Pinzon, Jeena Mathew, Juan Vasquez Mendez, José O. Alemán

New York

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, poster 1743-P

doi.org/10.2337/db25-1743-p

Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes